MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$4,926M
(6.37%↑ Y/Y)
Europe
$1,137M
(5.96%↑ Y/Y)
Rest Of World
$883M
(-2.86%↓ Y/Y)
Europe
$8M
(-27.27%↓ Y/Y)
Rest Of World
$6M
(0.00%↑ Y/Y)
Product
$6,946M
(5.04%↑ Y/Y)
Royalty Contract And
Other
$14M
(-74.07%↓ Y/Y)
Total revenues
$6,960M
(4.39%↑ Y/Y)
Operating income
$2,586M
(15.60%↑ Y/Y)
Other (income)
expense, net
$235M
(171.65%↑ Y/Y)
Total costs and
expenses
$4,374M
(-1.26%↓ Y/Y)
Income before income
taxes
$2,580M
(56.46%↑ Y/Y)
Interest expense
$240M
(-7.69%↓ Y/Y)
Selling, general and
administrative expenses
$1,451M
(15.34%↑ Y/Y)
Cost of goods sold
$1,445M
(-6.17%↓ Y/Y)
Research and development
expenses
$1,372M
(-0.51%↓ Y/Y)
Acquired in-process
research and development...
$107M
(-57.71%↓ Y/Y)
Net income
$2,021M
(53.69%↑ Y/Y)
Income tax expense
$559M
(67.37%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)